Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02184520 · ClinicalTrials.gov registry record · NA
A Prospective Randomized Postmarket Clinical Study of the TRANSITION Stabilization System
A NA study, sponsored by Globus Medical.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT02184520: Clinical Trial NA study, sponsored by Globus Medical.
NCT02184520 is a NA study that was terminated before completion, run by Globus Medical. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02184520, a NA study, was terminated before completion, sponsored by Globus Medical.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
This postmarket surveillance study is being conducted to evaluate the TRANSITION Stabilization System as an adjunct to fusion in the treatment of acute or chronic instabilities or deformities of the thoracic, lumbar and sacral spine. The study will involve up to 360 subjects at no more than 20 sites, to be treated with the TRANSITION Stabilization System. The data from this postmarket surveillance study will be provided to FDA in accordance with the 522 order.
Primary Outcome
The study was terminated prior to primary and secondary endpoint data collection, therefore no study data is reported.
Interventions
- DEVICE TRANSITION
- DEVICE REVERE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2016-04-19 |
| Est. Completion | 2017-05-18 |
| Phase | NA |
Why NCT02184520 stopped before completion
NCT02184520 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which TRANSITION is the first listed.
NCT02184520 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02184520 about?
NCT02184520 is a clinical study titled "A Prospective Randomized Postmarket Clinical Study of the TRANSITION Stabilization System". This postmarket surveillance study is being conducted to evaluate the TRANSITION Stabilization System as an adjunct to fusion in the treatment of acute or chronic instabilities or deformities of the thoracic, lumbar and sacral spine. The study will involve up to 360 subjects at no more than 20 sites...
What is the current status of trial NCT02184520?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2016-04-19. Estimated completion is 2017-05-18.
What interventions are being tested in trial NCT02184520?
The interventions under investigation include: TRANSITION (DEVICE), REVERE (DEVICE).
Who is sponsoring clinical trial NCT02184520?
This trial is sponsored by Globus Medical, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02184520's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI